Magnetic Resonance Angiography
10
1
1
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
10.0%
1 terminated out of 10 trials
85.7%
-0.8% vs benchmark
10%
1 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (10)
Comparison of Magnetic Resonance Coronary Angiography (MRCA) With Coronary Computed Tomography Angiography (CTA)
AI Models for Cerebral Aneurysms Segmentation, Detection and Stability Prediction
3D Time-of-Flight Magnetic Resonance Angiography in Hemodialysis Patients With Arteriovenous Fistula
Fatal Cerebral Infarction After Nasal Augmentation With Hyaluronic Acid
Ferumoxytol Enhanced Magnetic Resonance Angiography in Chronic Kidney Disease
Improving the Concentration of MR Contrast in the Arteries
Correlation Between Quantitative Analysis of Coronary MRA and FFR
GARDIAN, Gadovist in Routine Diagnostic Magnetic Resonance Imaging Administration in Non-selected Patients
Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Magnetic Resonance Angiography
CE-MRA Using Gadovist in Comparison to IA DSA Using Ultravist